Abstract
C36H37N4O6B, monoclinic, C2/c, a = 9.3404(4) Å, b = 19.8395(10) Å, c = 17.8985(9) Å, β = 103.301(5)°, V = 3226.0(3) Å3, Z = 4, Rgt(F) = 0.0626, wRref(F2) = 0.2086, T = 293 K.

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Data collection and handling.
| Crystal: | Colourless block |
| Size: | 0.20 × 0.20 × 0.20 mm |
| Wavelength: | Mo Kα radiation (0.71073 Å) |
| μ: | 0.9 cm−1 |
| Diffractometer, scan mode: | CCD, ω-scans |
| 2θmax, completeness: | 52.8°, >99% |
| N(hkl)measured, N(hkl)unique, Rint: | 6642, 3295, 0.022 |
| Criterion for Iobs, N(hkl)gt: | Iobs > 2 σ(Iobs), 1919 |
| N(param)refined: | 251 |
| Programs: | CrysAlisPro [1], SHELX [2], OLEX2 [3] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
| Atom | x | y | z | Uiso*/Ueq |
|---|---|---|---|---|
| N1 | 0.86117(18) | 0.20548(11) | 0.23166(11) | 0.0514(5) |
| O2 | 0.99611(17) | 0.29111(10) | 0.31730(11) | 0.0706(6) |
| N3 | 0.64122(19) | 0.16516(11) | 0.23894(11) | 0.0544(6) |
| H3a | 0.5617 | 0.1589 | 0.2544 | 0.065* |
| C4 | 0.8813(3) | 0.29583(14) | 0.35088(15) | 0.0598(7) |
| C5 | 0.7495(2) | 0.20798(13) | 0.26800(13) | 0.0495(6) |
| C6 | 0.8197(2) | 0.15757(13) | 0.17278(14) | 0.0531(6) |
| C7 | 0.6826(2) | 0.13269(13) | 0.17867(13) | 0.0505(6) |
| C8 | 0.7562(2) | 0.25529(13) | 0.33051(13) | 0.0521(6) |
| C9 | 0.6420(3) | 0.26153(15) | 0.36892(15) | 0.0647(8) |
| H9 | 0.5599 | 0.2337 | 0.3554 | 0.078* |
| O10 | 0.5437(2) | 0.31738(14) | 0.46661(13) | 0.1027(9) |
| B11 | 1.0000 | 0.2503(2) | 0.2500 | 0.0581(11) |
| C12 | 0.6089(3) | 0.08438(15) | 0.12722(16) | 0.0673(8) |
| H12 | 0.5183 | 0.0672 | 0.1311 | 0.081* |
| C13 | 0.8868(3) | 0.13621(16) | 0.11573(15) | 0.0670(8) |
| H13 | 0.9777 | 0.1528 | 0.1116 | 0.080* |
| C14 | 0.8887(3) | 0.34319(17) | 0.40973(17) | 0.0764(9) |
| H14 | 0.9709 | 0.3708 | 0.4242 | 0.092* |
| C15 | 0.7743(3) | 0.34887(18) | 0.44622(19) | 0.0833(10) |
| H15 | 0.7800 | 0.3805 | 0.4851 | 0.100* |
| C16 | 0.8108(3) | 0.08856(17) | 0.06484(17) | 0.0777(9) |
| H16 | 0.8524 | 0.0732 | 0.0255 | 0.093* |
| C17 | 0.6498(3) | 0.30773(17) | 0.42559(17) | 0.0745(9) |
| C18 | 0.6764(3) | 0.06327(17) | 0.07043(17) | 0.0767(9) |
| H18 | 0.6301 | 0.0312 | 0.0351 | 0.092* |
| C24 | 0.4144(4) | 0.2763(2) | 0.4449(2) | 0.1095(14) |
| H24A | 0.3680 | 0.2844 | 0.3920 | 0.164* |
| H24B | 0.3474 | 0.2873 | 0.4764 | 0.164* |
| H24C | 0.4415 | 0.2296 | 0.4517 | 0.164* |
| C20b | 0.184(2) | 0.0250(11) | 0.1239(15) | 0.173(6) |
| H20Ab | 0.1415 | 0.0467 | 0.0752 | 0.208* |
| H20Bb | 0.2066 | 0.0584 | 0.1644 | 0.208* |
| O21 | 0.2999(4) | −0.0138(3) | 0.1207(3) | 0.1667(14) |
| C22b | 0.081(2) | −0.0351(13) | 0.1434(16) | 0.171(8) |
| H22Ab | −0.0092 | −0.0186 | 0.1546 | 0.205* |
| H22Bb | 0.0597 | −0.0690 | 0.1033 | 0.205* |
| C23b | 0.188(3) | −0.0589(18) | 0.2128(17) | 0.222(9) |
| H23Ab | 0.1996 | −0.1075 | 0.2138 | 0.266* |
| H23Bb | 0.1642 | −0.0435 | 0.2599 | 0.266* |
| C26b | 0.329(2) | −0.020(2) | 0.1948(14) | 0.286(10) |
| H26Ab | 0.3415 | 0.0236 | 0.2196 | 0.343* |
| H26Bb | 0.4178 | −0.0464 | 0.2129 | 0.343* |
| C26Ac | 0.307(2) | −0.0677(9) | 0.1763(15) | 0.223(7) |
| H26Cc | 0.3048 | −0.1107 | 0.1502 | 0.268* |
| H26Dc | 0.4002 | −0.0647 | 0.2139 | 0.268* |
| C23Ac | 0.200(4) | −0.0655(11) | 0.2115(19) | 0.230(8) |
| H23Cc | 0.2381 | −0.0606 | 0.2665 | 0.276* |
| H23Dc | 0.1415 | −0.1063 | 0.2019 | 0.276* |
| C22Ac | 0.1089(19) | −0.0039(8) | 0.1783(9) | 0.139(5) |
| H22Cc | 0.0063 | −0.0160 | 0.1594 | 0.166* |
| H22Dc | 0.1159 | 0.0312 | 0.2167 | 0.166* |
| C20Ac | 0.1702(17) | 0.0170(9) | 0.1190(8) | 0.140(5) |
| H20Cc | 0.1023 | 0.0073 | 0.0705 | 0.169* |
| H20Dc | 0.1853 | 0.0654 | 0.1224 | 0.169* |
aOccupancy: 0.5; bOccupancy: 0.443(18); cOccupancy: 0.557(18).
Source of material
Reagents and solvents were of commercially available quality. Firstly, 2-(2′-hydroxy-5′-methoxyphenyl)-1H-benzimidazole was prepared according to the literature [4, 5] , and was processed by recrystallization from anhydrous ethanol twice. Secondly, the obtained compound (0.96 g, 4.0 mmol) was dissolved in 40 mL tetrahydrofuran (THF) under stirring, 10 mL of B(OH)3 (0.12 g, 2.0 mmol) solution in THF was added dropwise, and then refluxed for three hours. The solution was concentrated to 15 ml and filtered, the crude product was purified with ethanol by recrystallization to yield ca. 70%.
Experimental details
The tetrahydrofuran is disordered over two positions, which is treated as two parts with occupancy factors of 0.443 : 0.557. H atoms were positioned geometrically and allowed to ride on their parent atoms with d(C—H) = 0.93 Å (CH), 0.96 Å (CH3) or d(N—H) = 0.86 Å (CH) and Uiso(H) = 1.2Ueq(C, N).
Discussion
Electron-donating groups significantly increase the photoluminescence efficiency after being introduced into a conjugated structure. Organic borides are more stable than other organometallic complexes owing to their stronger B-O and B-N coordinate bonds [6]. Wang et al. [7], [8], [9], [10] have systematically studied the structure and photoluminescence properties of boron complexes for their potential application as functional material [11], [12], [13]. The title compound, has been obtained during a search for the complexes with better optical properties.
The B center, located on a twofold axis takes a N2O2-tetrahedral coordination geometry with two imidazolyl N and two oxhydryl O. The B—N and the B—O bond length is 1.544(3) Å and 1.458(3) Å, respectively. There are two symmetry related six-membered rings around the B atom formed with (B11 O2 C4 C5 C8 N1), the average deviation of which are 0.0266 Å, and the dihedral angle with the adjacent benzimidazole heterocycle is 2.12(0.14)°. In the crystal structure, molecules are linked into parallel chains along the a direction by intermolecular N—H⋯N hydrogen bonding.
Acknowledgement
The author would like to thank the Key Scientific Research Project of Colleges and Universities of Henan Province (No. 15A150061) for financial support.
References
1 Agilent Technologies: CrysAlisPRO Software system, version 1.171.35.15, Agilent Technologies UK Ltd, Oxford, UK, 2011.Search in Google Scholar
2 Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar
3 Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 42 (2009) 339–341.10.1107/S0021889808042726Search in Google Scholar
4 Zhu, H.; Huang, W. D.; Pu, J. Q.: Synthesis of benzimidazoles from o-nitroanilines in a one-step reductive cyclization process. J. Shanghai Univ. 13 (2007) 77–81.Search in Google Scholar
5 Yang, D. L.; Fokas, D.; Li, J. Z.; Yu, L. B.; Baldino, C. M.: A versatile method for the synthesis of benzimidazoles from o-nitroanilines and aldehydes in one step via a reductive cyclization. Synthesis 1 (2005) 0047–0056.10.1002/chin.200521131Search in Google Scholar
6 Hou, Q. F.; Zhao, L. Y.; Zhang, H. Y.; Wang, Y.; Jiang, S. M.: Synthesis and luminescent properties of two schiff-base boron complexes. J. Lumin. 126 (2007) 447–451.10.1016/j.jlumin.2006.08.094Search in Google Scholar
7 Wu, Q. G.; Esteghamatian, M.; Hu, N. X.; Wang, S. N.: Isomerism and blue electroluminescence of a novel organoboron compound: BIII2(O)(7-azain)2Ph2. Angew. Chem. Int. Ed. 38 (1999) 985–988.10.1002/(SICI)1521-3773(19990401)38:7<985::AID-ANIE985>3.0.CO;2-CSearch in Google Scholar
8 Liu, S. F.; Wu, Q. G.; Schmider, H. L.; Wang, S. N.: Syntheses, structures, and electroluminescence of new blue/green luminescent chelate compounds: Zn(2-py-in)2(THF), BPh2(2-py-in), Be(2-py-in)2, and BPh2(2-py-aza) [2-py-in = 2-(2-pyridyl)indole; 2-py-aza = 2-(2-pyridyl)-7-azaindole. J. Am. Chem. Soc. 122 (2000) 3671–3678.10.1021/ja9944249Search in Google Scholar
9 Liu, Q. D.; Mudadu, M. S.; Schmider, H.; Thummel, R.; Tao, Y.; Wang, S. N.: Tuning the luminescence and electroluminescence of diphenylboron complexes of 5-substituted 2-(2′-pyridyl)indoles. Organometallics. 21 (2002) 4743–4749.10.1021/om020446jSearch in Google Scholar
10 Liu, Q. D.; Mudadu, M. S.; Thummel, R.; Tao, Y.; Wang, S. N.: From blue to red: syntheses, structures, electronic, and electroluminescent properties of tunable luminescent N,N-chelate boron complexes. Adv. Funct. Mater. 15 (2005) 143—154.10.1002/adfm.200400081Search in Google Scholar
11 Liu, Y.; Guo, J. H.; Zhang, H. D.; Wang, Y.: Highly efficient white organic electroluminescence from a double-layer device based on a boron hydroxyphenylpyridine complex. Angew. Chem. Int. Ed. 41 (2002) 182–184.10.1002/1521-3773(20020104)41:1<182::AID-ANIE182>3.0.CO;2-BSearch in Google Scholar
12 Zhang, H. Y.; Huo, C.; Ye, K. Q.; Wang, Y.: Synthesis, structures, and luminescent properties of phenol-pyridyl boron complexes. Inorg. Chem. 45 (2006) 2788–2794.10.1021/ic051881jSearch in Google Scholar
13 Solé, S.; Gabbaï, F.: A bidentate borane as colorimetric fluoride ion sensor. Chem. Commun. 11 (2004) 1284–1285.10.1039/B403596HSearch in Google Scholar
©2017 Guo-Jie Yin et al., published by De Gruyter.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Articles in the same Issue
- Cover and Frontmatter
- Crystal structure of poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)manganese(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2) C42H40Cl2MnN6O10S2
- The crystal structure of 1,2-bis[2-methyl-5-(3-cyanophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluoro-cyclopent-1-ene, C29H16F6N2S2
- Crystal structure of the first characterized polymeric copper and sodium complex diaqua-(tris-acetato-κO,O′)(μ2-acetato-κO′′)dinatrium copper(II) monohydrate, C8H18CuNa2O11
- The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-3-yl-methylene)aniline, C18H22N2
- Crystal structure of methyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22N2O5
- Crystal structure of bis(1,3-bis(diphenylphosphino)propane-κ2P,P′)silver(I) trifluorosulfonate–methanol (1:0.5), [Ag(C27H26P2)]SO3CF3⋅0.5CH3OH
- Crystal structure of μ-1,4-bis(diphenylphosphine)butane-2,9-dimethyl-1,10-phenanthroline-κ2N:N′-bis(cyano-κC)dicopper(I)]-water, C58H56Cu2N6O2P2
- Crystal structure of N2,N6-bis(1-hydrazinyl-2-methyl-1-oxopropan-2-yl) pyridine-2,6-dicarboxamide, C15H23N7O4
- Crystal structure of 1,3-dimethyl-2-phenyl-1H-perimidin-3-ium iodide, C19H17IN2
- Crystal structure of diaqua-(2,2′-(butane-1,4-diyl)-bis(5-carboxy-1H-imidazole-4-carboxylato)-κ4O,O′,N,N′)cadmium(II) monohydrate, C14H18O11N4Cd
- Crystal structure of ethyl (E)-3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl) acrylate, C15H14Cl2FNO3
- Crystal structure of bis-(1-(4-chlorophenyl)-3-phenyl-4-thenoyl-1H-pyrazol-5-ol-κ2O,O′)-(N,N-dimethylformamide)zinc(II), C43H31Cl2N5O5S2Zn
- Crystal structure of tetrakis(μ3-2-(N-(2-hydroxyethyl)amino)ethoxo)-tetrachloro-tetra-cobalt(II) methanol solvate, C17H44Cl4Co4N4O9
- Crystal structure of 3-amino-1-(4-bromophenyl)-9-methoxy-1H-benzo[f]chromene-2-carbonitrile, C21H15BrN2O2
- Crystal structure of 2-amino-4-(4-isopropyl-phenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2-c]chromene, C22H18N2O3
- Crystal structure of 3-amino-8-methoxy-1-(4-methoxy phenyl)-1H-benzo[f]chromene-2-carbonitrile, C22H18N2O3
- Crystal structure of monoaqua-[6,6′-((1E,1′E)-(1,2-phenylene bis(azanylylidene))bis(methanylylidene))bis(4-bromo-2-nitrophenolato-κ4N,N′,O,O′)]zinc(II), C20H12Br2N4O7Zn
- Crystal structure of 11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one – acetonitril (1/2), C33H41N3O2
- Crystal structure of tert-butyl (phenylsulfinyl)carbamate, C11H15NO3S
- Crystal structure of catena-poly{diaqua-bis(3-(1H-1,2,4-triazol-1-yl)benzoato-κ2O:N)copper(II)} monohydrate, C18H18CuN6O7
- Crystal structure of tetraaqua-bis(3-(4H-1,2,4-triazol-4-yl)benzoato-κN)cobalt(II), C18H20CoN6O8
- The crystal structure of 4-bromo-N-cyclopropyl-2,5-difluorobenzenesulfonamide, C9H8BrF2NO2S
- Crystal structure of ([3,3′-bipyridine]-6,6′-dicarboxylato-κ2O:O′)-bis(1,2-bis(4-pyridyl)ethane-κ2N:N′)disilver(I) dihydrate, C37H35Ag2N5O6
- The crystal structure of (4-(1H-1,2,4-triazol-1-yl)benzoato-κN)-[4-(1H-1,2,4-triazol-1-yl)benzoic acid-κN]silver(I), C18H13AgN6O4
- Crystal structure of 3-(4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, C17H16O2
- Crystal structure of bis(2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)-5-methoxyphenolato-κ2O,N)copper(II), C36H38CuN4O6
- Crystal structure of poly[1,2-bis(1,2,4-triazol-4-yl)ethane-κ2N:N′]silver(I) bromate monohydrate]silver(I), C6H10AgBrN6O4
- The crystal structure of 2,3,5-triphenyl-2,3-dihydro-1H-tetrazol-1-ium 2,3-dioxoindoline-5-sulfonate, C27H19N5O5S
- Crystal structure of 3-(2-amino-1,3-selenazol-4-yl)-2H-chromen-2-one – dimethylformamide (1/1), C15H15N3O3Se
- Crystal structure of diethyl 3,3′-(diazene-1,2-diyl)(E)-dibenzoate, C18H18N2O4
- Crystal structure of cis-bis((1H-benzimidazol-2-yl)methanol-κN,O)-bis(isothiocyanato-κN)nickel(II), C18H16N6NiO2S2
- Crystal structure of bis(2-(2′-hydroxy-5′-methoxyphenyl)-1H-benzimidazole)boron – tetrahydrofuran (1/1), C36H37N4O6B
- Crystal structure of poly[aqua-bis(nitrato-κ2O,O′)-(μ3-1,3-benzimidazol-3-ium-1,3-diacetato-κ4O,O′:O′′:O′′′)dysprosium(III)], C11H11DyN4O11
- Crystal structure of n-butyl-tris(dicyclo-hexylamido)hafnium(IV), C40H75HfN3
- Crystal structure of (E)-1-[1-(3-chloro-4-fluoro-phenyl)ethylidene]-2-(2,4-dinitrophenyl)hydrazine, C28H20Cl2F2N8O8
- The crystal structure of ethyl 4-((2-hydroxybenzyl)amino)benzoate, a Schiff base, C16H17NO3
- Crystal structure of 3-(2-(4-isobutylphenyl)propanoyl)-1-methylimidazolidine-2,4-dione, C17H22N2O3
- Crystal structure of poly[(μ3-2-(pyrazin-2-ylthio)acetato-κ3N:O:S)silver(I)], C6H5AgN2O2S
- Crystal structure of (E)-1-(3-((E)-((2-hydroxynaphthalen-1-yl)methylene)amino)phenyl)ethanone O-benzyl oxime, C26H22N2O2
- Crystal structure of (E)-2,3-dihydroxybenzaldehyde O-(2-((((E)-1-(2,5-dihydroxyphenyl)ethylidene)amino)oxy)ethyl) oxime monohydrate, C17H20N2O7
- Crystal structure of 4-(chloromethyl)-3-nitrobenzoic acid, C8H6ClNO4
- Crystal stucture of 4-((10H-phenothiazin-10-yl)methyl)-2,6-di-tert-butylphenol, C27H31NOS
- The crystal structure of ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C13H10F3N3O4
- Crystal structure of catena-poly[di-(μ3-oxido-κ3O:O:O)-tetraoxido-(μ2-5′-(pyrazin-2-yl)-1H,2′H-3,3′-bi(1,2,4-triazole)-κ2N:N′)dimolybdenum(VI)], C8H6Mo2N8O6
- Crystal structure of (3,6-dioxocyclohexa-1,4-diene-1,4-bis(olato)-κ4O,O′:O′′,O′′′)-bis(tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′))-dizinc(II) bis(hexafluorophosphate(V)), C42H38F12N8O4P2Zn2
- Crystal structure of catena-poly[hexakis(μ2-2-acetylphenolato-κ3O:O,O′)trimanganese(II)], C48H42Mn3O12
- The crystal structure of 2,2-difluoro-4-(trifluoromethyl)-2,5-dihydro-[1,3,2]dioxaborinino[5,4-c]chromen-3-ium-2-uide, C11H6BF5O3
- Crystal structure of methyl (E)-2-(4-(diethylamino)-2-hydroxybenzylidene)hydrazine-1-carboxylate, C13H19N3O3
- The crystal structure of tert-butyl 2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylate, C10H15N3O2
- Crystal structure of 1,1-bis(η5-adamantylcyclopentadienyl)-3-phenyl-2-trimethylsilyl-2,3-dihydroisotitanazole, C42H55NSiTi
- Crystal structure of 2-(4-(2-(4-benzylpiperazin-1-yl)ethyl)benzyl)isoindoline-1,3-dione, C28H29N3O2
- Important impurity of Flupirtine – a single crystal study on ethyl (6-amino-5-((ethoxycarbonyl)amino)pyridin-2-yl)(4-fluorobenzyl)carbamate, C18H21FN4O4
- Crystal structure of ethyl 3-(4-methoxyphenyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-pyrazole-5-carboxylate, C22H22N2O5
- Crystal structure of 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate methanol solvate, C37H35N1O10
- The crystal structure of the inner salt of 2-[(aminoiminomethyl)amino]ethylcarbamic acid [systematic name: (2-((diaminomethylene)ammonio)ethyl)carbamate], C4H10N4O2
- Crystal structure of (8-hydroxy-5-nitroquinolinium) perchlorate – 8-hydroxy-5-nitroquinoline (1/1), C18H13ClN4O10
- The crystal structure of (5-methyl-1,2,4-oxadiazol-3-yl)ferrocene, C13H12FeN2O
- Crystal structure of methyl 1-(2-(fluorosulfonyl)ethyl)-2-oxocyclopentanecarboxylate, C9H13FO5S
- Crystal structure of the triclinic modification of 1-methyl-4-nitroimidzole, C4H5N3O2
- Corrigendum
- Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O
Articles in the same Issue
- Cover and Frontmatter
- Crystal structure of poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)manganese(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2) C42H40Cl2MnN6O10S2
- The crystal structure of 1,2-bis[2-methyl-5-(3-cyanophenyl)-3-thienyl]-3,3,4,4,5,5-hexafluoro-cyclopent-1-ene, C29H16F6N2S2
- Crystal structure of the first characterized polymeric copper and sodium complex diaqua-(tris-acetato-κO,O′)(μ2-acetato-κO′′)dinatrium copper(II) monohydrate, C8H18CuNa2O11
- The crystal structure of the Schiff base (E)-2,6-diisopropyl-N-(pyridin-3-yl-methylene)aniline, C18H22N2
- Crystal structure of methyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C20H22N2O5
- Crystal structure of bis(1,3-bis(diphenylphosphino)propane-κ2P,P′)silver(I) trifluorosulfonate–methanol (1:0.5), [Ag(C27H26P2)]SO3CF3⋅0.5CH3OH
- Crystal structure of μ-1,4-bis(diphenylphosphine)butane-2,9-dimethyl-1,10-phenanthroline-κ2N:N′-bis(cyano-κC)dicopper(I)]-water, C58H56Cu2N6O2P2
- Crystal structure of N2,N6-bis(1-hydrazinyl-2-methyl-1-oxopropan-2-yl) pyridine-2,6-dicarboxamide, C15H23N7O4
- Crystal structure of 1,3-dimethyl-2-phenyl-1H-perimidin-3-ium iodide, C19H17IN2
- Crystal structure of diaqua-(2,2′-(butane-1,4-diyl)-bis(5-carboxy-1H-imidazole-4-carboxylato)-κ4O,O′,N,N′)cadmium(II) monohydrate, C14H18O11N4Cd
- Crystal structure of ethyl (E)-3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl) acrylate, C15H14Cl2FNO3
- Crystal structure of bis-(1-(4-chlorophenyl)-3-phenyl-4-thenoyl-1H-pyrazol-5-ol-κ2O,O′)-(N,N-dimethylformamide)zinc(II), C43H31Cl2N5O5S2Zn
- Crystal structure of tetrakis(μ3-2-(N-(2-hydroxyethyl)amino)ethoxo)-tetrachloro-tetra-cobalt(II) methanol solvate, C17H44Cl4Co4N4O9
- Crystal structure of 3-amino-1-(4-bromophenyl)-9-methoxy-1H-benzo[f]chromene-2-carbonitrile, C21H15BrN2O2
- Crystal structure of 2-amino-4-(4-isopropyl-phenyl)-3-cyano-5-oxo-4H,5H-pyrano[3,2-c]chromene, C22H18N2O3
- Crystal structure of 3-amino-8-methoxy-1-(4-methoxy phenyl)-1H-benzo[f]chromene-2-carbonitrile, C22H18N2O3
- Crystal structure of monoaqua-[6,6′-((1E,1′E)-(1,2-phenylene bis(azanylylidene))bis(methanylylidene))bis(4-bromo-2-nitrophenolato-κ4N,N′,O,O′)]zinc(II), C20H12Br2N4O7Zn
- Crystal structure of 11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one – acetonitril (1/2), C33H41N3O2
- Crystal structure of tert-butyl (phenylsulfinyl)carbamate, C11H15NO3S
- Crystal structure of catena-poly{diaqua-bis(3-(1H-1,2,4-triazol-1-yl)benzoato-κ2O:N)copper(II)} monohydrate, C18H18CuN6O7
- Crystal structure of tetraaqua-bis(3-(4H-1,2,4-triazol-4-yl)benzoato-κN)cobalt(II), C18H20CoN6O8
- The crystal structure of 4-bromo-N-cyclopropyl-2,5-difluorobenzenesulfonamide, C9H8BrF2NO2S
- Crystal structure of ([3,3′-bipyridine]-6,6′-dicarboxylato-κ2O:O′)-bis(1,2-bis(4-pyridyl)ethane-κ2N:N′)disilver(I) dihydrate, C37H35Ag2N5O6
- The crystal structure of (4-(1H-1,2,4-triazol-1-yl)benzoato-κN)-[4-(1H-1,2,4-triazol-1-yl)benzoic acid-κN]silver(I), C18H13AgN6O4
- Crystal structure of 3-(4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, C17H16O2
- Crystal structure of bis(2-((E)-((4-((E)-1-(ethoxyimino)ethyl)phenyl)imino)methyl)-5-methoxyphenolato-κ2O,N)copper(II), C36H38CuN4O6
- Crystal structure of poly[1,2-bis(1,2,4-triazol-4-yl)ethane-κ2N:N′]silver(I) bromate monohydrate]silver(I), C6H10AgBrN6O4
- The crystal structure of 2,3,5-triphenyl-2,3-dihydro-1H-tetrazol-1-ium 2,3-dioxoindoline-5-sulfonate, C27H19N5O5S
- Crystal structure of 3-(2-amino-1,3-selenazol-4-yl)-2H-chromen-2-one – dimethylformamide (1/1), C15H15N3O3Se
- Crystal structure of diethyl 3,3′-(diazene-1,2-diyl)(E)-dibenzoate, C18H18N2O4
- Crystal structure of cis-bis((1H-benzimidazol-2-yl)methanol-κN,O)-bis(isothiocyanato-κN)nickel(II), C18H16N6NiO2S2
- Crystal structure of bis(2-(2′-hydroxy-5′-methoxyphenyl)-1H-benzimidazole)boron – tetrahydrofuran (1/1), C36H37N4O6B
- Crystal structure of poly[aqua-bis(nitrato-κ2O,O′)-(μ3-1,3-benzimidazol-3-ium-1,3-diacetato-κ4O,O′:O′′:O′′′)dysprosium(III)], C11H11DyN4O11
- Crystal structure of n-butyl-tris(dicyclo-hexylamido)hafnium(IV), C40H75HfN3
- Crystal structure of (E)-1-[1-(3-chloro-4-fluoro-phenyl)ethylidene]-2-(2,4-dinitrophenyl)hydrazine, C28H20Cl2F2N8O8
- The crystal structure of ethyl 4-((2-hydroxybenzyl)amino)benzoate, a Schiff base, C16H17NO3
- Crystal structure of 3-(2-(4-isobutylphenyl)propanoyl)-1-methylimidazolidine-2,4-dione, C17H22N2O3
- Crystal structure of poly[(μ3-2-(pyrazin-2-ylthio)acetato-κ3N:O:S)silver(I)], C6H5AgN2O2S
- Crystal structure of (E)-1-(3-((E)-((2-hydroxynaphthalen-1-yl)methylene)amino)phenyl)ethanone O-benzyl oxime, C26H22N2O2
- Crystal structure of (E)-2,3-dihydroxybenzaldehyde O-(2-((((E)-1-(2,5-dihydroxyphenyl)ethylidene)amino)oxy)ethyl) oxime monohydrate, C17H20N2O7
- Crystal structure of 4-(chloromethyl)-3-nitrobenzoic acid, C8H6ClNO4
- Crystal stucture of 4-((10H-phenothiazin-10-yl)methyl)-2,6-di-tert-butylphenol, C27H31NOS
- The crystal structure of ethyl 1-(4-nitrophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C13H10F3N3O4
- Crystal structure of catena-poly[di-(μ3-oxido-κ3O:O:O)-tetraoxido-(μ2-5′-(pyrazin-2-yl)-1H,2′H-3,3′-bi(1,2,4-triazole)-κ2N:N′)dimolybdenum(VI)], C8H6Mo2N8O6
- Crystal structure of (3,6-dioxocyclohexa-1,4-diene-1,4-bis(olato)-κ4O,O′:O′′,O′′′)-bis(tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′))-dizinc(II) bis(hexafluorophosphate(V)), C42H38F12N8O4P2Zn2
- Crystal structure of catena-poly[hexakis(μ2-2-acetylphenolato-κ3O:O,O′)trimanganese(II)], C48H42Mn3O12
- The crystal structure of 2,2-difluoro-4-(trifluoromethyl)-2,5-dihydro-[1,3,2]dioxaborinino[5,4-c]chromen-3-ium-2-uide, C11H6BF5O3
- Crystal structure of methyl (E)-2-(4-(diethylamino)-2-hydroxybenzylidene)hydrazine-1-carboxylate, C13H19N3O3
- The crystal structure of tert-butyl 2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxylate, C10H15N3O2
- Crystal structure of 1,1-bis(η5-adamantylcyclopentadienyl)-3-phenyl-2-trimethylsilyl-2,3-dihydroisotitanazole, C42H55NSiTi
- Crystal structure of 2-(4-(2-(4-benzylpiperazin-1-yl)ethyl)benzyl)isoindoline-1,3-dione, C28H29N3O2
- Important impurity of Flupirtine – a single crystal study on ethyl (6-amino-5-((ethoxycarbonyl)amino)pyridin-2-yl)(4-fluorobenzyl)carbamate, C18H21FN4O4
- Crystal structure of ethyl 3-(4-methoxyphenyl)-1-(2-(4-methoxyphenyl)-2-oxoethyl)-1H-pyrazole-5-carboxylate, C22H22N2O5
- Crystal structure of 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium 5-hydroxy-3-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-olate methanol solvate, C37H35N1O10
- The crystal structure of the inner salt of 2-[(aminoiminomethyl)amino]ethylcarbamic acid [systematic name: (2-((diaminomethylene)ammonio)ethyl)carbamate], C4H10N4O2
- Crystal structure of (8-hydroxy-5-nitroquinolinium) perchlorate – 8-hydroxy-5-nitroquinoline (1/1), C18H13ClN4O10
- The crystal structure of (5-methyl-1,2,4-oxadiazol-3-yl)ferrocene, C13H12FeN2O
- Crystal structure of methyl 1-(2-(fluorosulfonyl)ethyl)-2-oxocyclopentanecarboxylate, C9H13FO5S
- Crystal structure of the triclinic modification of 1-methyl-4-nitroimidzole, C4H5N3O2
- Corrigendum
- Crystal structure of 4-bromo-2-(1H-pyrazol-3-yl)phenol, C9H7BrN2O